These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 7693258)
1. [Walkaway systems in general practice: Behring ELISA Processor III]. Lanzer G; Beyer J; Weisshaar D Beitr Infusionsther; 1993; 31():218-23. PubMed ID: 7693258 [TBL] [Abstract][Full Text] [Related]
2. [Experiences with the ES-600 equipment]. Weisshaar D Beitr Infusionsther; 1993; 31():215-7. PubMed ID: 7693257 [TBL] [Abstract][Full Text] [Related]
3. [Instrument applications of three new Bio-Rad kits for HIV, HCV, HBSAG screening: Combo Genscreen Plus HIV 1/2 AG-AB, Monolisa anti HCV Plus V2, Monolisa HBSAG Plus, with the fully authomatic system Plato 3300]. Manetta T; Gay V; Spreafico G; Massaro A; Piantino P Minerva Med; 2001 Oct; 92(5):393-400. PubMed ID: 11675583 [TBL] [Abstract][Full Text] [Related]
4. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Laperche S; Boukatou G; Kouegnigan L; Nébié Y; Boulahi MO; Tagny CT; Yahaya R; Tapko JB; Murphy E; Lefrère JJ Transfusion; 2009 Aug; 49(8):1600-8. PubMed ID: 19527479 [TBL] [Abstract][Full Text] [Related]
5. [Analysis on quality control of blood in blood banks in a five-year program in Hunan province]. Lu YF; Yin P; Liu TY Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):574-6. PubMed ID: 12975011 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of hepatitis B surface antigen, anti-hepatitis C virus and anti-human immunodeficiency virus antibodies and syphilis seropositivity in blood donors: six years' seropositivity. Gunduz T; Mumcuoglu I; Güray M Int J Clin Pharmacol Res; 2005; 25(3):155-8. PubMed ID: 16366424 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia. Vardas E; Sitas F; Seidel K; Casteling A; Sim J Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243 [TBL] [Abstract][Full Text] [Related]
8. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors]. Cavdar E; Kuştimur S; Doğruman Al F Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694 [TBL] [Abstract][Full Text] [Related]
9. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias]. Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864 [TBL] [Abstract][Full Text] [Related]
10. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Ren FR; Lv QS; Zhuang H; Li JJ; Gong XY; Gao GJ; Liu CL; Wang JX; Yao FZ; Zheng YR; Zhu FM; Tiemuer MH; Bai XH; Shan H Transfusion; 2005 Nov; 45(11):1816-22. PubMed ID: 16271110 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018 [TBL] [Abstract][Full Text] [Related]
12. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations. Tozer RA P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849 [TBL] [Abstract][Full Text] [Related]
13. Multi-centre evaluation of the Behring ELISA Processor II. Steinmann J; Milbradt H; Steinkopf A; Schmidt B; Hellmut M; Weber C; Haeckel R J Clin Chem Clin Biochem; 1988 Jan; 26(1):43-56. PubMed ID: 3373151 [TBL] [Abstract][Full Text] [Related]
15. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of pooled screening for anti-HCV in two blood services set-ups. Novack L; Shinar E; Safi J; Soliman H; Yaari A; Galai N; Pliskin JS; Sarov B Trop Med Int Health; 2007 Mar; 12(3):415-21. PubMed ID: 17313513 [TBL] [Abstract][Full Text] [Related]
18. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779 [TBL] [Abstract][Full Text] [Related]
20. [Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico]. Ayala Gaytán JJ; Guerra Avalos FJ; Mora Brondo P; Casillas Romo A Rev Gastroenterol Mex; 1997; 62(4):250-3. PubMed ID: 9528294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]